Vinge Logotype
SvenskaEnglish 18D7E0DE-2035-40AE-A740-8F45A358A8F4 Login
  1. Home
  2. Mandates
  3. Vinge advises Helix Kapital on its investment in Sacpro
Mandate

Vinge advises Helix Kapital on its investment in Sacpro

December 19, 2023 M&A Corporate Commercial

Vinge has advised Helix Kapital in conjunction with it becoming a strategic stakeholder in Sacpro AB, a leading supplier and producer of tools and materials for pipe relining in properties. Together with Helix Kapital, Sacpro's founders and management will accelerate the company's growth by focusing on Northern Europe and the US.

Vinge's team primarily consisted of Johan Winnerblad, Robin Sultani, Martin Boström and Emma Gustavsson.

Related

Vinge advised Precise Biometrics

 Vinge has advised Precise Biometrics AB in connection with the merger with Fingerprint Cards.
March 27, 2026

Vinge has advised Xspray Pharma in connection with its rights issue

Vinge has advised Xspray Pharma AB (publ) in connection with a rights issue of approximately SEK 83 million before transaction costs, with an over-allotment issue of approximately SEK 30 million.
March 26, 2026

Vinge advises Diamyd Medical in connection with directed issuances of shares and warrants of up to SEK 1,166 million

 Vinge advises Diamyd Medical Aktiebolag (“Diamyd Medical”), listed on Nasdaq First North Growth Market, in connection with directed issuances of shares and warrants whereby Diamyd Medical receives gross proceeds of approximately SEK 1,166 million, if all warrants are exercised.
March 25, 2026